|
LifeSciencesWorld
|
|
MINRAD International, Inc. Announces Reduction in Workforce
11/21/08 12:54 AM
[NEWS]
ORCHARD PARK, N.Y., Nov. 20 /PRNewswire-FirstCall/ — MINRAD International, Inc. (Amex: BUF), announced effective today it will reduce its workforce by approximately 35% or 50 positions. Dave DiGiacinto, President and Chief Operating Officer, said, “We have taken this difficult, but necessary action to reduce our cost structure to conserve our cash in response to our current a…
|
|
National Drug Development Accelerator Launched
11/21/08 12:13 AM
[NEWS]
LENEXA, Kan., Nov. 20 /PRNewswire/ — KansasBio announced today a bioscience cluster activation initiative to promote the region's human health-care-related bioscience companies that serve the entire drug development continuum. Called the National Drug Development Accelerator (the Accelerator), the alliance comprises companies across Kansas and the Kansas City metropolitan area that represent many of the nation's preferred resources for drug development. KansasBio says the Accelerato…
|
|
|
Nature Biotechnology
|
|
Aligning interests
Aligning interests
Nature Biotechnology 26, 1199 (2008). doi:10.1038/nbt1108-1199
As sources of funding dwindle, could the health insurance sector do more to support biotech innovation and help itself at the same time?
|
|
Gunvalson decision sends shockwaves through industry
Gunvalson decision sends shockwaves through industry
Nature Biotechnology 26, 1201 (2008). doi:10.1038/nbt1108-1201
Author: Malorye Allison
|
|
|
Market Wire - Pharmaceuticals and Biotech
|
|
Recordati S.p.A.: Recordati S.p.A. SUBMITS FILE FOR APPROVAL OF SILODOSIN TO THE EMEA
11/21/08 8:48 AM
MILAN, ITALY (MARKET WIRE) RECORDATI SUBMITS FILE FOR APPROVAL OF SILODOSIN TO THE EMEA
|
|
Basilea Pharmaceutica AG: Zevtera(TM) (ceftobiprole medocaril), the novel anti-MRSA broad-spectrum antibiotic, receives a positive opinion from the CHMP
11/21/08 6:21 AM
BASEL, SWITZERLAND (MARKET WIRE) Basilea Pharmaceutica Ltd. announces that Zevtera(TM) (ceftobiprole medocaril), the first-in-class anti-MRSA broad-spectrum cephalosporin, received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for the treatment of complicated skin and soft tissue infections.
|
|
|
Technology Review Feed - Biomedicine Top Stories
|
|
Less-Invasive Brain Interfaces
11/21/08 5:00 AM
Electrical activity from the surface of the brain may be precise enough to control prostheses, research shows.
|
|
Healing with Laser Heat
11/19/08 5:00 AM
Surgical lasers could soon heal cuts as well as make incisions.
|
|
|
PR Newswire: Biotechnology
|
|
Promising Clinical Data on Gen-Probe's APTIMA(R) HPV Test Presented at Major European Medical Meeting
11/21/08 7:00 AM
|
|
BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference
11/20/08 9:51 PM
|
|
|
Yahoo! News: Biotechnology News
|
|
Researchers ID Suite of Genes in Aging Process
(HealthDay)
11/20/08 4:47 AM
HealthDay - WEDNESDAY, Nov. 19 (HealthDay News) -- Genetic biomarkers that
are highly accurate in determining physiological age have been identified
by researchers at California's Buck Institute for Age Research, who said
it may be possible to use these biomarkers to test anti-aging drugs.
|
|
European patent office restores breast cancer gene patent
(AFP)
11/19/08 8:50 PM
 AFP - The European Patent Office on Wednesday restored on appeal a controversial patent for a breast cancer gene that had been withdrawn from a US biotech firm, but granting it in a more restricted form than before.
|
|
http://news.biohealthmatics.com/feeds/rssreleases.aspx
http://news.biohealthmatics.com/feeds/rssreleases.aspx cannot be found.
|
